Etanercept therapy for psoriasis in a patient with numerous comorbidities

Clara De Simone, Giacomo Caldarola, Angelo Carbone

Research output: Contribution to journalArticle

2 Citations (Scopus)


A recent study demonstrated an association between psoriasis and dilated cardiomyopathy. Tumour necrosis factor alpha (TNFalpha) may be involved in the pathogenesis of dilated cardiomyopathy and therefore, anti-TNFalpha agents may play a role in the treatment of dilated cardiomyopathy. The case of a 51-year-old woman with severe psoriasis and numerous comorbidities including dilated cardiomyopathy is described. During treatment with etanercept, the patient's psoriasis improved rapidly without any worsening of her other conditions. Etanercept was safe and effective in the treatment of severe psoriasis in a patient with numerous comorbidities, including dilated cardiomyopathy.
Original languageEnglish
Pages (from-to)49-50
Number of pages2
JournalAmerican Journal of Clinical Dermatology
Publication statusPublished - 2010


  • etanercept
  • psoriasis


Dive into the research topics of 'Etanercept therapy for psoriasis in a patient with numerous comorbidities'. Together they form a unique fingerprint.

Cite this